Managing myelodysplastic syndromes.
Kurtin
Sandra
S
Arizona Cancer Center, Tucson, USA.
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001856:Bone Marrow Examination; D002986:Clinical Trials as Topic / Q000451:nursing; D020732:Cytogenetic Analysis; D016903:Drug Monitoring; D017707:Erythrocyte Transfusion; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing*; D009859:Oncology Nursing / Q000379:methods*; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide